STOCK TITAN

Gracell Biotechnologies to Participate in Fireside Chat at the BTIG Virtual Biotechnology Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Gracell Biotechnologies (NASDAQ: GRCL) will participate in the BTIG Virtual Biotechnology Conference 2021 on August 9-10, 2021. This includes one-on-one meetings and a fireside chat scheduled for August 10 at 9:30 AM ET. Gracell is a clinical-stage biopharmaceutical company focused on developing innovative cell therapies for cancer using its FasTCAR and TruUCAR technology platforms. These advancements aim to address challenges like lengthy manufacturing times and high costs associated with traditional CAR-T therapies.

Positive
  • None.
Negative
  • None.

SUZHOU, China and PALO ALTO, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it will participate in the BTIG Virtual Biotechnology Conference 2021 (details below).

BTIG Virtual Biotechnology Conference 2021

One-on-one and small group meetings: August 9-10, 2021

Fireside chat: Tuesday, August 10, 2021, 9:30 – 9:55am ET

For more information, please contact your BTIG representative.

About Gracell

Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit www.gracellbio.com

Follow @GracellBio on LinkedIn

Media contact

Marvin Tang

marvin.tang@gracellbio.com

Investor contact

Gracie Tong

gracie.tong@gracellbio.com


FAQ

When is the BTIG Virtual Biotechnology Conference 2021 for Gracell?

Gracell will participate in the BTIG Virtual Biotechnology Conference on August 9-10, 2021.

What is the timing of Gracell's fireside chat at the conference?

Gracell's fireside chat is scheduled for August 10, 2021, from 9:30 to 9:55 AM ET.

What are Gracell's main technology platforms?

Gracell utilizes FasTCAR and TruUCAR technology platforms to develop cell therapies.

What are the goals of Gracell's cell therapies?

Gracell aims to create affordable and effective cell therapies that address major challenges in conventional CAR-T therapies.

What stock symbol represents Gracell Biotechnologies?

Gracell Biotechnologies is represented by the stock symbol GRCL.

Gracell Biotechnologies Inc.

NASDAQ:GRCL

GRCL Rankings

GRCL Latest News

GRCL Stock Data

989.87M
165.04M
16.39%
63.11%
1.23%
Biotechnology
Healthcare
Link
China
Suzhou